Taxotere Chemosensitivity Evaluation in Mice Prostate Tumor: Validation and Diagnostic Accuracy of Quantitative Measurement of Tumor Characteristics by MRI,PET,and Histology of Mice Tumor

Abstract

Increased PET and MRI image intensities of mouse prostate tumors were correlated with histostaining tumor characteristics. The hypothesis was that increased intracellular sodium μMRI signal intensities and flouro-2-deoxy-glucose utilization by μPET in apoptosis rich regions in tumors were positively correlated as chemosensitivity assay of Taxotere. The PC-3 cancer cell line induced prostate tumor MRI and PET images and histology slices were digitally captured and compared in pre- and post-Taxotere treated tumors. The optimization of inversion recovery MRI parameters was done to generate sodium images of phantom. The ¹⁸FDG biotransformation was optimized to measure PET image intensities. A criterion was developed to evaluate malignancy by histology. For correlation, regression analysis was done using imaging, histology, and immunostaining data from PC3 tumor after 24 and 48 hours post-Taxotere treatment. Apoptosis indices were calculated by histostaining and ss-DNA antibody assay. Sodium MRI and PET signal intensity distributions were comparable at specific locations relatively and measured in tumor tissue regions. In tumors, Taxotere induced an increase in intracellular sodium MRI signal 30% (p<0.001) with decreased tumor size (20%; p<0.001) and micro-PET showed FDG uptake increase 15% (p<0.001) with decreased tumor size (10%; p<0.001) than that of control tumors after 24 hours. Histological features indicated tumor risk (high ‘intracellular/extracellular ratio’, high mitotic index, and apoptotic index), decreased tumor viability (reduced mitotic figures, reduced diploidy or aneuploidy, and proliferation index) after Taxotere treatment. These features in co-registered intracellular sodium, μPET hypermetabolic, and monoclonal antibody (ss-DNA) sensitive regions showed (% difference > 6%). Apoptosis rich regions showed characteristic nuclei with S phase DNA histogram, appearing brighter on IC-Na images and mild active on PET images (sensitivity=65%; specificity=70%). In conclusion, MRI and PET multimodal imaging may be rapid non-invasive chemosensitivity assay to monitor the drug anticancer effect.

Keywords

MRI and PET correlation Apoptosis index Prostate tumor Validation Quantitative chemo sensitivity

References

Kline

E. X.

Petrylak

D. P.

Szabolcs

Alderson

P. O.

Weisfeldt

M. L.

Cannon

P. J.

Katz

Rapid in vivo monitoring of chemotherapeutic response using weighted sodium magnetic resonance imaging. Clin Cancer Res 6, 2146–2156 (2000).

Schepkin

V. D.

Ross

B. D.

Chenevert

T. L.

Rehemtulla

Sharma

Kumar

Stojanovska

Sodium magnetic resonance imaging of chemotherapeutic response in a rat glioma. Magn Reson Med 53, 85–92 (2005).

Navon

. Complete Elimination of the extracellular 23Na NMR Signal in Triple Quantum filtered spectra of rat hearts in the presence of Shift Reagents. Magn Res Med 30, 503–506 (1993).

Sharma

Kline

R. P.

E. X.

Katz

J. K.

Rapid in vivo Taxotere quantitative chemosensitivity response by 4.23 Tesla sodium MRI and histo-immunostaining features in N-Methyl-N-Nitrosourea induced breast tumors in rats. Cancer Cell Int 5, 26 (2005).

Somer

E. J.

Marsden

P. K.

Benatar

N. A.

Goodey

O'Doherty

M. J.

Smith

M. A.

PET-MR image fusion in soft tissue sarcoma: Accuracy, reliability and practicality of interactive point-based and automated mutual information techniques. Eur J Nucl Med Mol Imaging 30, 54–62 (2003).

Karam

J. A.

Mason

R. P.

Koeneman

K. S.

Antich

P. P.

Benaim

E. A.

Hsieh

J. T.

Molecular imaging in prostate cancer. J Cell Biochem 90, 473–483 (2003).

Ouwerkerk

Bleich

K. B.

Gillen

J. S.

Pomper

M. G.

Bottomley

P. A.

Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. Radiology 227, 529–537 (2003).

Vaquero

J. J.

Desco

Pascau

Santos

Lee

Siedel

Green

M. V.

PET, CT, and MR Image Registration of the Rat Brain and Skull. IEEE Transactions Nuclear Science 48, 1440–1445 (2001).

Press

W. H.

Teukolsky

S. A.

Vetterling

W. T.

Flannery

B. P.

Numerical Recipes in C, 2nd ed , pp. 412–420. Cambridge, U.K.: Cambridge University Press, UK (1992).

10.

Bottcher

Maierl

Hecht

Matis

Liebich

H. G.

Automatic image registration of three-dimensional images of the head of cats and dogs by use of maximization of mutual information. Am J Vet Res 65, 1680–1687 (2004).

11.

Arun

K. S.

Huang

T. S.

Blostein

S. D.

Least squares fitting of two 3D point sets. IEEE Trans Pattern Anal Image Recogn 9, 699–700 (1987).

12.

West

Fitzpatrick

J. M.

Wang

M. Y.

Dawant

B. M.

Maurer

C. R.

Kessler

R. M.

Comparison and evaluation of retrospective intermodality brain image registration techniques. J Comput Assist Tomog 21, 554–566 (1997).

13.

Maes

Collignon

Vandermeulen

Marchal

Suetens

Multimodality Image registration by maximization of mutual information. IEEE Trans Med Imag 16, 187–198 (1997).

14.

Fei

Wang

Muzic

R. F.

Jr Flask

Wilson

D. L.

Duerk

J. L.

Feyes

D. K.

Oleinick

N. L.

Deformable and rigid registration of MRI and microPET images for photodynamic therapy of cancer in mice. Med Phys 33, 753–760 (2006).

15.

Woods

R. P.

Mazziotta

J. C.

Cherry

S. R.

MRI-PET registration with automated algorithm. J Computer Assisted Tomography 17, 536–546 (1993).

16.

Skerl

Likar

Pernus

A protocol for evaluation of similarity measures for rigid registration. IEEE Trans Med Imaging 25, 779–791 (2006).

17.

Hayakawa

Uemura

Ishiwata

Shimada

Ogi

Nagaoka

A PET-MRI registration technique for PET studies of the rat brain. Nucl Med Biol 27, 121–125 (2000).

18.

Lyons

S. K.

Advances in imaging mouse tumour models

in vivo. J Pathol 205, 194–205 (2005).

19.

Humm

J. L.

Ballon

Y. C.

Ruan

Chui

Tulipano

P. K.

Erdi

Koutcher

Zakian

Urano

Zanzonico

Mattis

Dyke

Chen

Harrington

O'Donoghue

J. A.

Ling

C. C.

A stereotactic method for the three-dimensional registration of multi-modality biologic images in animals: NMR, PET, histology, and autoradiography. Med Phys 30, 2303–2314 (2003).

20.

Sharma

Kline

R. P.

Flow cytometry, MRI, PET and NMR spectroscopy methods of non-invasive drug monitoring in prostate tumor: Technical Note. Proceedings of 16th IEEE Comp Based Medical Systems. 2003. Mt Sinai Medical Center, NY; 16:263–268 (2003).

21.

Sharma

Kline

R. P.

Chemosensitivity assay in mice prostate tumor: Preliminary report of flow cytometry, DNA fragmentation, ion ratiometric methods of anti-neoplastic drug monitoring. Cancer Cell International 4, 3 (2004).